Tricyclic compounds

US8426411B2 · kind B2 · utility

Assignee

• Abbott Laboratories · US

Inventors

• Neil Wishart · Jefferson, US
• Kristine E. Frank · Portage, US
• Michael Friedman · Jerusalem, IL
• Dawn M. George · Charlton, US
• Kent D. Stewart · Gurnee, US
• Grier A. Wallace · Sterling, US

Key dates

• Filing date: Dec 1, 2010
• Grant date: Apr 23, 2013
• Expiry date: Dec 1, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D513/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.